INCYTE CORP

Services-Commercial Physical & Biological Research·WILMINGTON, DE·FY end 12/31·CIK 879169

Named Executive Officers

FY 2025

Executive	Salary	Stock	Options	Bonus / Inc.	Other	Total
Steven H. SteinExecutive Vice President, Chief Medical Officer and Head of Late-stage Development	$835.1K	$3.5M	$1.3M	$696.1K	$35.8K	$6.3M
William J. Meury · CEO	—	—	—	—	—	—

William J. Meury · FY 2025

TSR % vs. CEO comp actually paid · 6 fiscal years · Item 402(v) disclosure

TSR

CEO comp

FY20

-0%

$13M

FY21

+14%

$6M

FY22

-8%

$16M

FY23

-28%

$8M

FY24

-21%

$25M

FY25

+14%

$55M

Need at least two fiscal years of proxy data to draw the trend line. The ingestion worker will populate prior-year proxies as it processes them.